Cambridge Bioscience Corp.

Cambridge Bioscience Corp. — FDA 510(k) Submissions

Cambridge Bioscience Corp. has submitted 5 FDA 510(k) premarket notifications since 1985, of which 5 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Antigens, Cf (including Cf Control), Adenovirus 1-33, Enzyme Linked Immunoabsorbent Assay, Rotavirus, Reagent, Borrelia Serological Reagent . Use the specialty filter in the sidebar to narrow results.